aTyr Pharma | LIFE - Loan Capital

Stock Price
0.89
Daily Change
0.08 9.25%
Monthly
18.69%
Yearly
-77.28%
Q1 Forecast
0.86

aTyr Pharma reported $398K in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Ardelyx USD 202.14M 27.07M Sep/2025
aTyr Pharma USD 398K 204K Sep/2025
Biogen USD 6.29B 1.4M Sep/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Cipla INR 2.98B 454.6M Sep/2025
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
CSL USD 10.69B 1.37B Jun/2025
Galapagos EUR 5.76M 290K Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Grifols EUR 10.67B 564.4M Sep/2025
Novartis USD 24.24B 174M Sep/2025
Roche Holding CHF 27.43B 966M Dec/2025
United Therapeutics USD 100M 100M Jun/2024